advertisement

---

Stuschke M 23

Showing records 1 to 23 | Display all abstracts from Stuschke M

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Dalbah S
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---

95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Jabbarli L; Guberina M
Clinical and Experimental Ophthalmology 2021; 49: 357-367

---

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Bechrakis NE
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---

95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Guberina M; Biewald E
Clinical and Experimental Ophthalmology 2021; 49: 357-367

---

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Thomasen H
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---

95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Biewald E; Flühs D
Clinical and Experimental Ophthalmology 2021; 49: 357-367

---

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Flühs D
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---

95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Flühs D
Clinical and Experimental Ophthalmology 2021; 49: 357-367

---

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Flühs D
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---

95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Guberina N
Clinical and Experimental Ophthalmology 2021; 49: 357-367

---

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Rating P; Guberina M; Guberina M
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---

95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Le Guin CHD
Clinical and Experimental Ophthalmology 2021; 49: 357-367

---

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Stuschke M
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---

95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Sauerwein W
Clinical and Experimental Ophthalmology 2021; 49: 357-367

---

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Stuschke M
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---

95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Bornfeld N
Clinical and Experimental Ophthalmology 2021; 49: 357-367

---

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Fiorentzis M
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---

95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Bornfeld N; Stuschke M
Clinical and Experimental Ophthalmology 2021; 49: 357-367

---

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Bornfeld N
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---

95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Stuschke M
Clinical and Experimental Ophthalmology 2021; 49: 357-367

---

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Bornfeld N; Biewald E
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---

95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Bechrakis NE
Clinical and Experimental Ophthalmology 2021; 49: 357-367

---

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Biewald E
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

---